Stage IA Breast Cancer Withdrawn Phase Trials for Azacitidine (DB00928)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01292083Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryTreatment